Taken together, our analysis reveals that SkM from middle-aged individuals with obesity exhibit increased CS markers which are associated with a dysmetabolic state, reduced expression of key metabolic gene GLUT4 and diminished levels of PAX7, which is crucial for the maintenance and development of SkM. This evidence concerns the gene PAX7 and obesity disorder.